European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, October 2025

Oncology drug tenders in Portugal in October 2025: 193 tenders published (+86% month on month, -20% year on year), estimated at €6,290,455 in total, and 194 contracts awarded (+53% month on month, -3% year on year), worth €4,684,408 (awarded value). Buyers with the most tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (38), Unidade Local de Saúde da Região de Leiria, E. P. E. (20) and Unidade Local de Saúde de Santo António, E. P. E. (16); most contracts won: Janssen Cilag Farmaceutica, Lda. (15), Novartis Farma-Prod.farmacêuticos,sa. (13) and MYLAN, Lda. (8). On average 13.4 bids per contract; 15% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
193
Contracts awarded
194
Contract value awarded
€4,684,408
Bids per contract
13.4
Tenders published per month
05001K1.5KOct 24: 241Oct 24: 241Oct 24Nov 24: 230Nov 24: 230Nov 24Dec 24: 967Dec 24: 967Dec 24Jan 25: 1,160Jan 25: 1,160Jan 25Feb 25: 931Feb 25: 931Feb 25Mar 25: 1,431Mar 25: 1,431Mar 25Apr 25: 1,156Apr 25: 1,156Apr 25May 25: 271May 25: 271May 25Jun 25: 116Jun 25: 116Jun 25Jul 25: 717Jul 25: 717Jul 25Aug 25: 361Aug 25: 361Aug 25Sep 25: 104Sep 25: 104Sep 25Oct 25: 193Oct 25: 193193Oct 25
Contracts awarded per month
05001K1.5KOct 24: 199Oct 24: 199Oct 24Nov 24: 386Nov 24: 386Nov 24Dec 24: 1,212Dec 24: 1,212Dec 24Jan 25: 1,017Jan 25: 1,017Jan 25Feb 25: 1,143Feb 25: 1,143Feb 25Mar 25: 1,418Mar 25: 1,418Mar 25Apr 25: 971Apr 25: 971Apr 25May 25: 117May 25: 117May 25Jun 25: 123Jun 25: 123Jun 25Jul 25: 736Jul 25: 736Jul 25Aug 25: 225Aug 25: 225Aug 25Sep 25: 127Sep 25: 127Sep 25Oct 25: 194Oct 25: 194194Oct 25

The highlighted bar is October 2025. Hover a bar for its figure; the table below has every value.

FigureOctober 2025September 2025ChangeOctober 2024Change
Tenders published193104+86%241-20%
Estimated value€6,290,455€4,420,864+42%€9,667,039-35%
Buyers2410+140%23+4%
Contracts awarded194127+53%199-3%
Contract value (awarded)€4,684,408€1,510,621+210%€418,619+1,019%
Winners4428+57%39+13%
Bids per contract13.45.1—6.2—
Single-bid contracts15%55%—37%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 15

Procedures

  • not stated 178
  • Restricted procedure 15

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in October 2025?
193 (by 24 buyers); for comparison, September 2025: 104, October 2024: 241.
Who won the most oncology drug tenders in Portugal in October 2025?
By number of contracts: Janssen Cilag Farmaceutica, Lda. (15), Novartis Farma-Prod.farmacêuticos,sa. (13), MYLAN, Lda. (8), Grindeks Kalceks Portugal Sociedade Unipessoal Lda (7) and Astrazeneca-Produtos Farmacêuticos,lda. (7); 44 companies won contracts in all.
Which buyers published the most oncology drug tenders in October 2025?
Unidade Local de Saúde de Santa Maria, E. P. E. (38), Unidade Local de Saúde da Região de Leiria, E. P. E. (20), Unidade Local de Saúde de Santo António, E. P. E. (16), Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (13) and Unidade Local de Saúde do Alto Minho, EPE (ULSAM) (13).
How competitive were oncology drug tenders in Portugal in October 2025?
On average 13.4 bids per contract (79 contracts with a known number of bids); 15% of contracts had a single bid.
What were the contracts worth in October 2025?
€4,684,408 (awarded value, 194 contracts); median about €330,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.